Sepsis is the leading cause of
acute kidney injury in
critically ill patients.
Tumor necrosis factor-α (TNF-α) has been implicated in the pathogenesis of septic kidney injury; however, the sites and mechanisms of renal TNF-α production during
sepsis remain to be defined. In the present study, we showed that TNF-α expression is increased in medullary thick ascending limbs (MTALs) of mice with
sepsis induced by cecal
ligation and
puncture. Treatment with
lipopolysaccharide (LPS) for 3 h in vitro also increased MTAL TNF-α production.
Sepsis and LPS increased MTAL TNF-α expression through activation of the
myeloid differentiation factor 88 (MyD88)-IL-1 receptor-associated
kinase 1-ERK signaling pathway. Pretreatment with
monophosphoryl lipid A (MPLA), a nontoxic
immunomodulator that protects against
bacterial infection, eliminated the
sepsis- and LPS-induced increases in MTAL TNF-α production. The suppressive effect of MPLA on TNF-α was mediated through activation of a
phosphatidylinositol 3-kinase-dependent pathway that inhibits MyD88-dependent ERK activation. This likely involves MPLA-
phosphatidylinositol 3-kinase-mediated induction of Tollip, which negatively regulates the MyD88-ERK pathway by inhibiting activation of
IL-1 receptor-associated kinase 1. These regulatory mechanisms are similar to those previously shown to mediate the effect of MPLA to prevent
sepsis-induced inhibition of MTAL [Formula: see text] absorption. These results identify the MTAL as a site of local TNF-α production in the kidney during
sepsis and identify molecular mechanisms that can be targeted to attenuate renal TNF-α expression. The ability of MPLA pretreatment to suppress MyD88-dependent ERK signaling in the MTAL during
sepsis has the dual beneficial effects of protecting tubule transport functions and attenuating harmful proinflammatory responses.